Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Glatiramer price, strengths & recalls

Generic of Copaxone, Glatopa

Pharmacies pay $1,190.04 for 30 mL of Glatiramer 20 mg/mL, 1 mL prefilled syringe this week, and from $986.77 to $1,190.04 across its 2 priced strengths and forms. 5 manufacturers make it. It has 6 recalls on record, none ongoing. Its official label last changed on August 20, 2026.

Generic
Pharmacies pay$1,190.04for 30 mL of 20 mg/mL, 1 mL prefilled syringe-5.0% in 4 weeks
Fair cash price
$1,379.05
Strengths
2
Makers
5
Updated
Nov 11

Glatiramer price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
20 mg/mL, 1 mL prefilled syringe$39.67$1,190.04 / 30 mL-5.0%-15.2%
40 mg/mL, 1 mL prefilled syringe$82.23$986.77 / 12 mL-4.5%-20.4%

Brand names of glatiramer

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls6 recalls on record, latest May 16, 2018

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for glatiramer? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 20, 2026
Version2 of 2
EffectiveAug 19, 2026
Read the label

These highlights do not include all the information needed to use GLATIRAMER ACETATE INJECTION safely and effectively. See full prescribing information for GLATIRAMER ACETATE INJECTION.GLATIRAMER ACETATE injection, for subcutaneous useInitial U.S. Approval: 1996

This drug has a boxed warning

BOXED WARNING

WARNING: ANAPHYLACTIC REACTIONS

Cases of life-threatening and fatal anaphylaxis have been reported with Glatiramer acetate injection. Anaphylaxis can occur at any time following initiation of therapy, from as early as after the first dose, up to years following initiation of therapy.

● Make patients aware of the symptoms of anaphylaxis, which may overlap with those of an immediate post-injection reaction; instruct them to seek immediate medical care should these symptoms occur. Prompt identification of anaphylaxis is important to avoid a delay in treatment [see Warnings and Precautions (5.1)].

● Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to Glatiramer acetate injection, including anaphylaxis. If an anaphylactic reaction occurs, treatment with Glatiramer acetate injection must be immediately discontinued. Unless a clear alternative etiology is identified, Glatiramer acetate injection must be permanently discontinued [see Contraindications (4) and Warnings and Precautions (5.1)].

WARNING: ANAPHYLACTIC REACTIONS

See full prescribing information for complete boxed warning.

Life-threatening and fatal anaphylaxis, which can occur at any time following initiation of therapy (from as early as after the first dose, up to years after initiation of treatment), has been reported in patients receiving Glatiramer acetate injection.

● Make patients aware of the symptoms of anaphylaxis, which may overlap with those of an immediate post-injection reaction. Prompt identification of anaphylaxis is important to avoid a delay in treatment (5.1).

● Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to Glatiramer acetate injection, including anaphylaxis (4).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA020622 · Teva Pharms USA
First approved
December 20, 1996 (30 years ago)
Latest approved change
June 22, 2026
Approved label
PDF, Jun 23, 2026
Generic makers
10 approved generic applications on the market

Glatiramer questions

How much does glatiramer cost without insurance?

Pharmacies pay about $1,190.04 for 30 mL of glatiramer 20 mg/mL, 1 mL prefilled syringe ($39.67 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,379.05. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of glatiramer?

Glatiramer is sold as Copaxone, Glatopa. The generic has the same active ingredient and usually costs far less.

Is glatiramer in shortage?

No shortage is reported for glatiramer right now. We check the national shortage list every day.

Has glatiramer been recalled?

6 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the glatiramer label last change?

The official label was last updated on August 20, 2026 (version 2). See what changed.

Talk about glatiramer

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.